Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120115) titled 'Mechanism of NETs/METs-Induced Neuroapoptosis Mediating the Rapid Progression of Pancreatic Cancer' on March 9.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Jiangsu Province Hospital ( The First Affiliated Hospital of Nanjing Medical University)
Condition:
pancreatic cancer
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-09
Target Sample Size: Pancreatic cancer patients:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=305262
Published by HT Digital Content Services with permission fro...